 |
|
The Human T-Cell Leukemia-Lymphoma Virus in the Southeastern United States
Douglas W. Blayney, MD;
William A. Blattner, MD;
Marjorie Robert-Guroff, PhD;
Elaine S. Jaffe, MD;
Richard I. Fisher, MD;
Paul A. Bunn, Jr, MD;
Maurice G. Patton, MD;
Howard R. Rarick, DPH;
Robert C. Gallo, MD
JAMA. 1983;250(8):1048-1052.
Abstract
The human T-cell leukemia-lymphoma virus (HTLV) is a recently described RNA tumor virus associated with human T-cell malignant neoplasms. In two geographic areas, Japan and the Caribbean basin, clusters of adult T-cell leukemia-lymphoma are "sentinel diseases" and have suggested an underlying prevalence of HTLV infection in both family members of the index cases and in the population. Four cases of lymphoma from the United States are described as illustrative of the sentinel disease. Serological studies of families and of a small population sample suggest that HTLV infection is endemic in certain parts of the southeastern United States at rates similar to those seen in Caribbean blacks but at a lower rate than that observed in southwestern Japan.
(JAMA 1983;250:1048-1052)
Author Affiliations
From the Environmental Epidemiology Branch (Drs Blayney and Blattner), the Laboratory of Tumor Cell Biology (Drs Robert-Guroff and Gallo), the Laboratory of Pathology (Dr Jaffe), the Medicine Branch (Dr Fisher), and the NCI-Navy Medical Oncology Branch (Dr Bunn), National Cancer Institute, Bethesda, Md; the Richmond County Health Department, Augusta, Ga (Dr Patton); and the Department of Health and Rehabilitative Services, Jacksonville, Fla (Dr Rarick).
Footnotes
Reprint requests to the Environmental Epidemiology Branch, Family Studies Section, National Cancer Institute, Landow Bldg, Room 4C18, Bethesda, MD 20205 (Dr Blayney).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Expression of Glucose Transporter 1 Confers Susceptibility to Human T-Cell Leukemia Virus Envelope-Mediated Fusion
Coskun and Sutton
J. Virol. 2005;79:4150-4158.
ABSTRACT
| FULL TEXT
Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2
Tarsis et al.
J. Virol. 1998;72:841-846.
ABSTRACT
| FULL TEXT
The Impact of Human T-Lymphotrophic Virus Type I/II Infection on the Prognosis of Sexually Acquired Cases of Acquired Immunodeficiency Syndrome
Gotuzzo et al.
Arch Intern Med 1992;152:1429-1432.
ABSTRACT
Human T-Lymphotropic Virus (HTLV I-II) Infection among Patients in an Inner-City Emergency Department
Kelen et al.
ANN INTERN MED 1990;113:368-372.
ABSTRACT
The Inexact Use of Fisher's Exact Test in Six Major Medical Journals
McKinney et al.
JAMA 1989;261:3430-3433.
ABSTRACT
Mycosis Fungoides in the United States: Increasing Incidence and Descriptive Epidemiology
Weinstock and Horm
JAMA 1988;260:42-46.
ABSTRACT
Adult T-Cell Leukemia/Lymphoma in Brooklyn
Dosik et al.
JAMA 1988;259:2255-2257.
ABSTRACT
Adult T-Cell Leukemia/Lymphoma Associated With Human T-Lymphotropic Virus Type I (HTLV-I) Infection--North Carolina
JAMA 1988;259:483-484.
Human T-Cell Lymphotropic Virus Type I Infection in Neonates
Hara et al.
Arch Pediatr Adolesc Med 1987;141:764-765.
ABSTRACT
Prevalence of Antibodies to HTLV-I, -II, and -III in Intravenous Drug Abusers From an AIDS Endemic Region
Robert-Guroff et al.
JAMA 1986;255:3133-3137.
ABSTRACT
Smoldering HTLV-Associated T-Cell Leukemia
Abrams et al.
Arch Intern Med 1985;145:2257-2258.
ABSTRACT
HTLV-I Antibodies in Childhood Leukemia
Williams et al.
JAMA 1985;253:2496-2496.
ABSTRACT
|
